{
    "2021-02-09": [
        [
            {
                "time": "",
                "original_text": "连缐CEO|声佗医疗普强凌：“硅谷科技”切入听力辅助赛道突破垄断掘金千亿蓝海",
                "features": {
                    "keywords": [
                        "声佗医疗",
                        "硅谷科技",
                        "听力辅助",
                        "赛道突破",
                        "垄断",
                        "千亿蓝海"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "J司压轴发了1888元新春红包",
                "features": {
                    "keywords": [
                        "新春红包",
                        "1888元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "励晶太平洋(00575.HK)：江苏万邦医药已取得药品审评中心的临床试验审批",
                "features": {
                    "keywords": [
                        "励晶太平洋",
                        "江苏万邦医药",
                        "药品审评",
                        "临床试验审批"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业一周观察：疫情或转为持久战 行业景气度提升",
                "features": {
                    "keywords": [
                        "医药行业",
                        "疫情",
                        "持久战",
                        "景气度提升"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "第四批国采中标结果 百亿市场进口替代开始",
                "features": {
                    "keywords": [
                        "第四批国采",
                        "中标结果",
                        "百亿市场",
                        "进口替代"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智通港股通持股分析|2月9日",
                "features": {
                    "keywords": [
                        "智通港股通",
                        "持股分析"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "跟拥有多家上市公司的企业集团聊聊协同价值管理",
                "features": {
                    "keywords": [
                        "上市公司",
                        "企业集团",
                        "协同价值管理"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}